181 related articles for article (PubMed ID: 20450918)
21. Human framework adaptation of a mouse anti-human IL-13 antibody.
Fransson J; Teplyakov A; Raghunathan G; Chi E; Cordier W; Dinh T; Feng Y; Giles-Komar J; Gilliland G; Lollo B; Malia TJ; Nishioka W; Obmolova G; Zhao S; Zhao Y; Swanson RV; Almagro JC
J Mol Biol; 2010 Apr; 398(2):214-31. PubMed ID: 20226193
[TBL] [Abstract][Full Text] [Related]
22. Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides.
Knappik A; Ge L; Honegger A; Pack P; Fischer M; Wellnhofer G; Hoess A; Wölle J; Plückthun A; Virnekäs B
J Mol Biol; 2000 Feb; 296(1):57-86. PubMed ID: 10656818
[TBL] [Abstract][Full Text] [Related]
23. Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site.
Schier R; McCall A; Adams GP; Marshall KW; Merritt H; Yim M; Crawford RS; Weiner LM; Marks C; Marks JD
J Mol Biol; 1996 Nov; 263(4):551-67. PubMed ID: 8918938
[TBL] [Abstract][Full Text] [Related]
24. Structural consequences of humanizing an antibody.
Holmes MA; Foote J
J Immunol; 1997 Mar; 158(5):2192-201. PubMed ID: 9036965
[TBL] [Abstract][Full Text] [Related]
25. Structure of an IgNAR-AMA1 complex: targeting a conserved hydrophobic cleft broadens malarial strain recognition.
Henderson KA; Streltsov VA; Coley AM; Dolezal O; Hudson PJ; Batchelor AH; Gupta A; Bai T; Murphy VJ; Anders RF; Foley M; Nuttall SD
Structure; 2007 Nov; 15(11):1452-66. PubMed ID: 17997971
[TBL] [Abstract][Full Text] [Related]
26. The importance of framework residues H6, H7 and H10 in antibody heavy chains: experimental evidence for a new structural subclassification of antibody V(H) domains.
Jung S; Spinelli S; Schimmele B; Honegger A; Pugliese L; Cambillau C; Plückthun A
J Mol Biol; 2001 Jun; 309(3):701-16. PubMed ID: 11397090
[TBL] [Abstract][Full Text] [Related]
27. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
Wu H; Nie Y; Huse WD; Watkins JD
J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
[TBL] [Abstract][Full Text] [Related]
28. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
[TBL] [Abstract][Full Text] [Related]
29. A mutational analysis of binding interactions in an antigen-antibody protein-protein complex.
Dall'Acqua W; Goldman ER; Lin W; Teng C; Tsuchiya D; Li H; Ysern X; Braden BC; Li Y; Smith-Gill SJ; Mariuzza RA
Biochemistry; 1998 Jun; 37(22):7981-91. PubMed ID: 9609690
[TBL] [Abstract][Full Text] [Related]
30. I-Ak polymorphisms define a functionally dominant region for the presentation of hen egg lysozyme peptides.
Rosloniec EF; Vitez LJ; Beck BN; Buerstedde JM; McKean DJ; Landais D; Benoist C; Mathis D; Freed JH
J Immunol; 1989 Jul; 143(1):50-8. PubMed ID: 2786533
[TBL] [Abstract][Full Text] [Related]
31. Crystal structure of HEL4, a soluble, refoldable human V(H) single domain with a germ-line scaffold.
Jespers L; Schon O; James LC; Veprintsev D; Winter G
J Mol Biol; 2004 Apr; 337(4):893-903. PubMed ID: 15033359
[TBL] [Abstract][Full Text] [Related]
32. Atypical antigen recognition mode of a shark immunoglobulin new antigen receptor (IgNAR) variable domain characterized by humanization and structural analysis.
Kovalenko OV; Olland A; Piché-Nicholas N; Godbole A; King D; Svenson K; Calabro V; Müller MR; Barelle CJ; Somers W; Gill DS; Mosyak L; Tchistiakova L
J Biol Chem; 2013 Jun; 288(24):17408-19. PubMed ID: 23632026
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.
Fan ZC; Shan L; Goldsteen BZ; Guddat LW; Thakur A; Landolfi NF; Co MS; Vasquez M; Queen C; Ramsland PA; Edmundson AB
J Mol Recognit; 1999; 12(1):19-32. PubMed ID: 10398393
[TBL] [Abstract][Full Text] [Related]
34. Conserved amino acid networks involved in antibody variable domain interactions.
Wang N; Smith WF; Miller BR; Aivazian D; Lugovskoy AA; Reff ME; Glaser SM; Croner LJ; Demarest SJ
Proteins; 2009 Jul; 76(1):99-114. PubMed ID: 19089973
[TBL] [Abstract][Full Text] [Related]
35. Structural analysis of the nurse shark (new) antigen receptor (NAR): molecular convergence of NAR and unusual mammalian immunoglobulins.
Roux KH; Greenberg AS; Greene L; Strelets L; Avila D; McKinney EC; Flajnik MF
Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11804-9. PubMed ID: 9751746
[TBL] [Abstract][Full Text] [Related]
36. Functional characterization of an anti-estradiol antibody by site-directed mutagenesis and molecular modelling: modulation of binding properties and prominent role of the V(L) domain in estradiol recognition.
Coulon S; Pellequer JL; Blachère T; Chartier M; Mappus E; Chen Sw SW; Cuilleron CY; Baty D
J Mol Recognit; 2002; 15(1):6-18. PubMed ID: 11870917
[TBL] [Abstract][Full Text] [Related]
37. Design and validation of a synthetic VH repertoire with tailored diversity for protein recognition.
Almagro JC; Quintero-Hernández V; Ortiz-León M; Velandia A; Smith SL; Becerril B
J Mol Recognit; 2006; 19(5):413-22. PubMed ID: 16881059
[TBL] [Abstract][Full Text] [Related]
38. Construction of an artificially randomized IgNAR phage display library: screening of variable regions that bind to hen egg white lysozyme.
Ohtani M; Hikima J; Jung TS; Kondo H; Hirono I; Aoki T
Mar Biotechnol (NY); 2013 Feb; 15(1):56-62. PubMed ID: 22552958
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the horse V(H) repertoire and comparison with the human IGHV germline genes, and sheep, cattle and pig V(H) sequences.
Almagro JC; Martinez L; Smith SL; Alagon A; Estevez J; Paniagua J
Mol Immunol; 2006 Apr; 43(11):1836-45. PubMed ID: 16337682
[TBL] [Abstract][Full Text] [Related]
40. Functional characterization of the somatic hypermutation process leading to antibody D1.3, a high affinity antibody directed against lysozyme.
England P; Nageotte R; Renard M; Page AL; Bedouelle H
J Immunol; 1999 Feb; 162(4):2129-36. PubMed ID: 9973487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]